health π¬ Advanced gastric cancer shows long-term survival with personalized care
Doctors reported exceptional long-term survival in a patient with HER2-positive metastatic gastric adenocarcinoma. The 65-year-old man was treated at a private hospital in New Delhi starting in 2018. His initial treatment included CAPOX chemotherapy plus trastuzumab, and he later underwent conversion surgery. The team managed subsequent isolated recurrences in 2021 and 2024 using targeted local therapies. This case proves precision oncology offers renewed hope for advanced gastric cancer patients.